Copyright
©The Author(s) 2019.
World J Clin Cases. Aug 26, 2019; 7(16): 2287-2301
Published online Aug 26, 2019. doi: 10.12998/wjcc.v7.i16.2287
Published online Aug 26, 2019. doi: 10.12998/wjcc.v7.i16.2287
Table 2 SUCRA values and effect size in comparison to placebo
Nausea (Heterogeneity variance = 0.17) | Vomiting (Heterogeneity variance = 0.00) | ||||||||
Rank | Treatment | SUCRA | OR | 95%CI | Rank | Treatment | SUCRA | OR | 95%CI |
1 | Midazolam | 86.10 | 0.20 | (0.04, 0.96) | 1 | Fentanyl | 79.90 | 0.25 | (0.11, 0.56) |
2 | Fentanyl | 77.10 | 0.34 | (0.15, 0.79) | 2 | Sufentanil | 70.70 | 0.34 | (0.14, 0.80) |
3 | Pethidine | 4.30 | 3.15 | (1.04, 9.57) | 3 | Pethidine | 1.10 | 3.71 | (1.81, 7.58) |
1 | Clonidine | 79.30 | 0.26 | (0.06, 1.10) | 1 | Midazolam | 89.90 | 0.11 | (0.01, 1.00) |
2 | Tramadol | 58.50 | 0.51 | (0.06, 4.58) | 2 | Clonidine | 69.30 | 0.35 | (0.10, 1.26) |
3 | Magnesium sulfate | 53.00 | 0.65 | (0.09, 4.88) | 3 | Magnesium sulfate | 48.70 | 0.65 | (0.10, 4.10) |
4 | Dexmedetomidine | 44.50 | 0.82 | (0.38, 1.76) | 4 | Dexmedetomidine | 38.10 | 0.87 | (0.43, 1.74) |
5 | Sufentanil | 37.20 | 0.97 | (0.45, 2.06) | 5 | Placebo | 32.20 | ||
6 | Placebo | 34.80 | 6 | Morphine | 20.10 | 1.42 | (0.62, 3.26) | ||
7 | Morphine | 25.10 | 1.30 | (0.47, 3.56) | |||||
Pruritus (heterogeneity variance = 1.18) | Hypotension (heterogeneity variance = 0.15) | ||||||||
Rank | Treatment | SUCRA | OR | 95%CI | Rank | Treatment | SUCRA | OR | 95%CI |
1 | Morphine | 22.60 | 6.54 | (1.02, 41.88) | 1 | Midazolam | 99.70 | 0.04 | (0.01, 0.19) |
2 | Sufentanil | 7.40 | 20.37 | (2.44, 169.96) | 2 | Sufentanil | 74.50 | 0.47 | (0.23, 0.96) |
1 | Tramadol | 76.90 | 0.40 | (0.01, 12.33) | 1 | Magnesium sulfate | 56.50 | 0.68 | (0.16, 2.87) |
2 | Clonidine | 75.90 | 0.34 | (0.00, 29.96) | 2 | Morphine | 55.20 | 0.68 | (0.11,4.42) |
3 | Dexmedetomidine | 71.90 | 0.74 | (0.13, 4.17) | 3 | Placebo | 41.20 | ||
4 | Placebo | 68.00 | 4 | Dexmedetomidine | 32.50 | 1.22 | (0.31, 4.85) | ||
5 | Magnesium sulfate | 48.60 | 2.05 | (0.08, 52.19) | 5 | Pethidine | 31.70 | 1.18 | (0.59, 2.36) |
6 | Pethidine | 39.60 | 2.98 | (0.50, 17.73) | 6 | Fentanyl | 31.50 | 1.18 | (0.52, 2.67) |
7 | Fentanyl | 39.10 | 2.84 | (0.58, 13.91) | 7 | Tramadol | 27.30 | 1.39 | (0.33, 5.77) |
Bradycardia (heterogeneity variance = 0.00) | |||||||||
Rank | Treatment | SUCRA | OR | 95%CI | |||||
1 | Pethidine | 82.30 | 0.32 | (0.07, 1.42) | |||||
2 | Dexmedetomidine | 52.70 | 0.84 | (0.14, 4.87) | |||||
3 | Fentanyl | 49.50 | 1.00 | (0.06, 16.44) | |||||
4 | Morphine | 47.70 | 1.00 | (0.02, 40.86) | |||||
5 | Placebo | 46.70 | |||||||
6 | Sufentanil | 39.10 | 1.21 | (0.44, 3.37) | |||||
7 | Tramadol | 32.00 | 1.72 | (0.07, 41.24) |
- Citation: Zhang YW, Zhang J, Hu JQ, Wen CL, Dai SY, Yang DF, Li LF, Wu QB. Neuraxial adjuvants for prevention of perioperative shivering during cesarean section: A network meta-analysis following the PRISMA guidelines. World J Clin Cases 2019; 7(16): 2287-2301
- URL: https://www.wjgnet.com/2307-8960/full/v7/i16/2287.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i16.2287